BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Bellerophon Therapeutics Inc.

Headquarters: Warren, NJ, United States
Year Founded: 2014
Status: Public
Industry Sector: HealthTechnology
CEO: Craig R. Jalbert
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -0.01
Exchange/Ticker 1: NASDAQ:BLPH
Exchange/Ticker 2: N/A
Latest Market Cap: $146,800